Measurable benefits of off-site module construction are becoming more evident, and it is emerging as a viable method for delivering a greater degree of predictability. Furthermore, market constraints driven by shortages of craft labor, lagging productivity, project complexity, and competitive forces are contributing to biopharma’s move toward modularization.
Demand increase for process equipment coupled with shortage of construction labor will require proactive engagement with vendors/contractors and greater due diligence to ensure predictable results.
In today's global business environment, life science companies need lean operations and cost optimization to ensure a sustainable profit margin. These challenges provide an impetus to unleash suppliers’ value to directly impact the bottom line.